Browsing by Keyword : Glioblastoma
Showing results 25 to 37 of 37
| Pub Year | | Title | Author(s) |
| 2015 | | Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance. | 김세혁, 우현구 |
| 2013 | | RGD peptide-conjugated multimodal NaGdF4:Yb3+/Er3+ nanophosphors for upconversion luminescence, MR, and PET imaging of tumor angiogenesis. | 박선 |
| 2019 | | Secretome analysis of patient-derived GBM tumor spheres identifies midkine as a potent therapeutic target | 이진구 |
| 2022 | | SHMT1 siRNA-Loaded hyperosmotic nanochains for blood-brain/tumor barrier post-transmigration therapy | 정연훈 |
| 2023 | | SMO-CRISPR-mediated apoptosis in CD133-targeted cancer stem cells and tumor growth inhibition | 정연훈 |
| 2016 | | Suppression of 14-3-3gamma-mediated surface expression of ANO1 inhibits cancer progression of glioblastoma cells | 김철호, 이복순 |
| 1997 | | The Effect of All-trans and 13-cis-retinoic Acid in Medulloblastoma and Glioblastoma Cell Culture | 김성환, 김세혁, 안영환, 윤수한, 조경기, 조기홍 |
| 2020 | | Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma | 우현구 |
| 2020 | | Treatment Results for Recurrent Glioblastoma and Alteration of Programmed Death-Ligand 1 Expression After Recurrence | 노태훈 |
| 2020 | | Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial | 김세혁 |
| 2017 | | Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma | 김세혁, 우현구 |
| 2018 | | Validation of a novel molecular RPA classification in glioblastoma (GBM-molRPA) treated with chemoradiation: A multi-institutional collaborative study | 오영택, 조오연 |
| 2015 | | Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups. | 이다근 |
1
